389 related articles for article (PubMed ID: 36808622)
1. HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment.
Missiaen R; Lesner NP; Simon MC
EMBO J; 2023 Mar; 42(6):e112067. PubMed ID: 36808622
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and cancer cell metabolism.
Huang D; Li C; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives.
Gonzalez-Avila G; Sommer B; Flores-Soto E; Aquino-Galvez A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069210
[TBL] [Abstract][Full Text] [Related]
6. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.
Martinez-Outschoorn UE; Trimmer C; Lin Z; Whitaker-Menezes D; Chiavarina B; Zhou J; Wang C; Pavlides S; Martinez-Cantarin MP; Capozza F; Witkiewicz AK; Flomenberg N; Howell A; Pestell RG; Caro J; Lisanti MP; Sotgia F
Cell Cycle; 2010 Sep; 9(17):3515-33. PubMed ID: 20855962
[TBL] [Abstract][Full Text] [Related]
7. Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.
Hatfield SM; Kjaergaard J; Lukashev D; Belikoff B; Schreiber TH; Sethumadhavan S; Abbott R; Philbrook P; Thayer M; Shujia D; Rodig S; Kutok JL; Ren J; Ohta A; Podack ER; Karger B; Jackson EK; Sitkovsky M
J Mol Med (Berl); 2014 Dec; 92(12):1283-92. PubMed ID: 25120128
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?
Huang Y; Lin D; Taniguchi CM
Sci China Life Sci; 2017 Oct; 60(10):1114-1124. PubMed ID: 29039125
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factors: crosstalk between inflammation and metabolism.
Shay JE; Celeste Simon M
Semin Cell Dev Biol; 2012 Jun; 23(4):389-94. PubMed ID: 22525300
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts.
Goggins E; Kakkad S; Mironchik Y; Jacob D; Wildes F; Krishnamachary B; Bhujwalla ZM
Neoplasia; 2018 Feb; 20(2):131-139. PubMed ID: 29247885
[TBL] [Abstract][Full Text] [Related]
11. In vivo optical imaging of tumor stromal cells with hypoxia-inducible factor activity.
Miyabara H; Hirano R; Watanabe S; Soriano JCC; Watanabe H; Kuchimaru T; Kitada N; Kadonosono T; Maki SA; Kondoh G; Kizaka-Kondoh S
Cancer Sci; 2023 Oct; 114(10):3935-3945. PubMed ID: 37482942
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the HIF switch in the tumor and its immune microenvironment.
Cowman SJ; Koh MY
Trends Cancer; 2022 Jan; 8(1):28-42. PubMed ID: 34743924
[TBL] [Abstract][Full Text] [Related]
13. Effects of hypoxia and HIFs on cancer metabolism.
Mucaj V; Shay JE; Simon MC
Int J Hematol; 2012 May; 95(5):464-70. PubMed ID: 22539362
[TBL] [Abstract][Full Text] [Related]
14. The impact of hypoxia on immune state in cancer.
Mortezaee K; Majidpoor J
Life Sci; 2021 Dec; 286():120057. PubMed ID: 34662552
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2018; 1072():171-175. PubMed ID: 30178341
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression.
Satija S; Kaur H; Tambuwala MM; Sharma P; Vyas M; Khurana N; Sharma N; Bakshi HA; Charbe NB; Zacconi FC; Aljabali AA; Nammi S; Dureja H; Singh TG; Gupta G; Dhanjal DS; Dua K; Chellappan DK; Mehta M
Curr Mol Pharmacol; 2021; 14(3):321-332. PubMed ID: 33494692
[TBL] [Abstract][Full Text] [Related]
17. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
18. CopA3 treatment suppressed multidrug resistivity in HCT-116 cell line by p53-induced degradation of hypoxia-inducible factor 1α.
Dey DK; Gahlot H; Chang SN; Kang SC
Life Sci; 2023 Sep; 329():121933. PubMed ID: 37451396
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets.
Kling L; Schreiber A; Eckardt KU; Kettritz R
J Leukoc Biol; 2021 Jul; 110(1):61-75. PubMed ID: 33070368
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia Mediates Tumor Malignancy and Therapy Resistance.
Luo W; Wang Y
Adv Exp Med Biol; 2019; 1136():1-18. PubMed ID: 31201713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
